Product Information

PHENYTOIN 125 MG/5 ML SUSP is a generic product labeled by Mylan Pharmaceuticals Inc., priced at $0.0756 per ML under NDC 59762053102. Its NADAC has been published 328 times since May 13, 2020.

FDA first approved this application before 1982. Its Orange Book therapeutic-equivalence code is AB — FDA rates it therapeutically equivalent to (substitutable for) its reference product.

The Low Outlier badge above means this manufacturer's average price in the Phenytoin market falls below Q1 − 1.5·IQR across all competing manufacturers. We only apply this flag in markets with four or more competitors. Full definition: glossary → outlier.

PHENYTOIN 125 MG/5 ML SUSP

Phenytoin
$0.0756per ML
Low Outlier

Strength

125 mg/5mL

NDC

59762053102

Classification

Generic

Dosage Form

SUSPENSION

Route

ORAL

Effective Date

8/19/2026

Active Ingredients

PHENYTOIN

Approval Type

Authorized Generic (NDA)

FDA Application

NDA008762

FDA Approved

Before 1982

TE Code

AB

On Market Since

4/22/2020

Pharmacological Classes

Anti-epileptic Agent
Cytochrome P450 1A2 Inducers
Cytochrome P450 2B6 Inducers
Cytochrome P450 2C19 Inducers
Cytochrome P450 2C8 Inducers
Cytochrome P450 2C9 Inducers
Cytochrome P450 2D6 Inducers
Cytochrome P450 3A Inducers
Decreased Central Nervous System Disorganized Electrical Activity

Price Statistics

The NADAC for PHENYTOIN 125 MG/5 ML SUSP has been published 328 times since May 13, 2020, and over the history we have for it it has held within roughly two percent of its current level. The table below summarizes its recorded NADAC range and movement.

Current price$0.0756 per ML
All-time high$0.0845 (May 13, 2026)
All-time low$0.0582 (Jul 19, 2023)
52-week high$0.0845
52-week low$0.0655
Median price$0.0746
Average price$0.0742
Largest weekly change+32.2% (May 18, 2022)
Weeks tracked328
Tracking sinceMay 13, 2020

Price History

1W

-3.4%

1M

-3.4%

3M

-9.7%

6M

-9.5%

1Y

+5.5%

3Y

+29.9%

5Y

+0.5%

All

+0.7%

Generic Alternatives

The matcher finds 1 manufacturer offering a NADAC-published product with this drug's active ingredient and strength in a comparable dosage form (cheapest from each manufacturer, up to 10 shown below). None of the shown alternatives sit below the current price. These are candidates to verify clinically, not guaranteed substitutes — see our generic drug prices guide.

Frequently asked questions

What is the NADAC price of PHENYTOIN 125 MG/5 ML SUSP?

The current National Average Drug Acquisition Cost (NADAC) for PHENYTOIN 125 MG/5 ML SUSP, manufactured by Mylan Pharmaceuticals Inc., is $0.0756 per ML (NDC 59762053102), effective Aug 19, 2026.

How has the price of PHENYTOIN 125 MG/5 ML SUSP changed over time?

Over the history we have for it, the NADAC for PHENYTOIN 125 MG/5 ML SUSP has held within roughly two percent of its current level. It has been tracked across 328 weekly CMS publications since May 13, 2020.

What are the highest and lowest recorded NADAC prices for PHENYTOIN 125 MG/5 ML SUSP?

Since May 13, 2020, the NADAC for PHENYTOIN 125 MG/5 ML SUSP has ranged from a low of $0.0582 (Jul 19, 2023) to a high of $0.0845 (May 13, 2026), with a median of $0.0746 per ML.

Are there cheaper alternatives to PHENYTOIN 125 MG/5 ML SUSP?

1 manufacturer publishes a NADAC-priced product with the same active ingredient and strength as PHENYTOIN 125 MG/5 ML SUSP in a comparable dosage form, but none are currently priced below it.

Who manufactures PHENYTOIN 125 MG/5 ML SUSP?

PHENYTOIN 125 MG/5 ML SUSP (NDC 59762053102) is labeled by Mylan Pharmaceuticals Inc., and CMS classifies it as a generic product.